Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Cash from Investing Activities of $9.7 million for Q3 2025, up 2069.92% year-over-year from $446652.7 in Q3 2024, and down 34.6% quarter-over-quarter from $14.8 million in Q2 2025.
Vicarious Surgical (RBOT) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Cash from Investing Activities for 6 consecutive years, with $9.7 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash from Investing Activities rose 2069.92% year-over-year to $9.7 million; the TTM figure through Sep 2025 stood at $43.6 million (up 1814.16% YoY), while the FY2024 annual figure was $6.9 million, up 114.99% from the prior year.
- Cash from Investing Activities eased to $9.7 million in Q3 2025 per RBOT's latest filing, from $14.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $14.8 million in Q2 2025 and bottomed at -$43.8 million in Q1 2023.
- Historically, Cash from Investing Activities has averaged -$865105.3 across 5 years, with a median of -$492000.0 in 2024.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 2067.56% — and 2025, when it soared 3303.47%.
- Vicarious Surgical's Cash from Investing Activities stood at -$867000.0 in 2021, then retreated by 14.42% to -$992000.0 in 2022, then soared by 608.57% to $5.0 million in 2023, then soared by 186.42% to $14.4 million in 2024, then plunged by 32.93% to $9.7 million in 2025.
- Business Quant data shows RBOT's Cash from Investing Activities at $9.7 million in Q3 2025, $14.8 million in Q2 2025, and $4.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.69 Mn |
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Jun 30, 2025 | 14.82 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Mar 31, 2025 | 4.61 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Dec 31, 2024 | 14.45 Mn |
| Sep 30, 2024 | -492,000.00 |
| Sep 30, 2024 | -492,000.00 |
| Jun 30, 2024 | -6.95 Mn |
| Jun 30, 2024 | -6.95 Mn |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 5.05 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | -644,000.00 |
| Sep 30, 2023 | -644,000.00 |
| Jun 30, 2023 | -6.36 Mn |
| Jun 30, 2023 | -6.36 Mn |